McCarthy et al. 2007. J Gene Med. 9(6):511-20. PMID: 17471586.
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer. Frezza et al. 2011. Nature. 477(7363):225-8. PMID: 21849978.
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Pollard et al. 2007. Cancer Cell. 11(4):311-9. PMID: 17418408.
Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.